What It Targets Our Epithalon peptide is designed to target: Telomere attrition and genomic instability, key hallmarks of biological aging that correlate with agerelated disease risk. Agerelated decline in melatonin production and circadian rhythm amplitude that affects sleep quality, mood, and hormonal balance. Biomarkers and symptoms of aging such as reduced recovery, low resilience to stress, and tired but wired sleep patterns in midlife and beyond. Clients already focused on longevity who want to explore precision protocols that connect peptides, telomere testing, and lifestyle design
PMID: 53 ChowdhuryRSinhaBSankarMJTanejaSBhandariNRollinsNet al
Folate stability during high pressure processing is comparable to that during heat treatments
The Schirmer test demonstrated enhanced tear production in the 10 mg and 14 mg groups at the 90-day assessment
MOMP results in the release of multiple mitochondrial proteins, most notably cytochrome c (CYCS), into the cytosol
Sometimes small adjustments make a huge difference